Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
Essaidi-Laziosi M, Pérez-Rodríguez FJ, Alvarez C, Sattonnet-Roche P, Torriani G, Bekliz M, Adea K, Lenk M, Suliman T, Preiser W, Müller MA, Drosten C, Kaiser L, Eckerle I. Essaidi-Laziosi M, et al. Among authors: preiser w. Virus Res. 2024 Jan 2;339:199255. doi: 10.1016/j.virusres.2023.199255. Epub 2023 Nov 6. Virus Res. 2024. PMID: 38389324 Free PMC article.
Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters.
Lemmer Y, Chapman R, Abolnik C, Smith T, Schäfer G, Hermanus T, du Preez I, Goosen K, Sepotokele KM, Gers S, Suliman T, Preiser W, Shaw ML, Roth R, Truyts A, Chipangura J, Magwaza M, Mahanjana O, Moore PL, O'Kennedy MM. Lemmer Y, et al. Among authors: preiser w. Vaccine. 2024 Feb 6;42(4):738-744. doi: 10.1016/j.vaccine.2024.01.036. Epub 2024 Jan 18. Vaccine. 2024. PMID: 38238112 Free article.
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
Davies MA, Morden E, Rosseau P, Arendse J, Bam JL, Boloko L, Cloete K, Cohen C, Chetty N, Dane P, Heekes A, Hsiao NY, Hunter M, Hussey H, Jacobs T, Jassat W, Kariem S, Kassanjee R, Laenen I, Le Roux S, Lessells R, Mahomed H, Maughan D, Meintjes G, Mendelson M, Mnguni A, Moodley M, Murie K, Naude J, Ntusi NAB, Paleker M, Parker A, Pienaar D, Preiser W, Prozesky H, Raubenheimer P, Rossouw L, Schrueder N, Smith B, Smith M, Solomon W, Symons G, Taljaard J, Wasserman S, Wilkinson RJ, Wolmarans M, Wolter N, Boulle A. Davies MA, et al. Among authors: preiser w. medRxiv [Preprint]. 2022 Jul 1:2022.06.28.22276983. doi: 10.1101/2022.06.28.22276983. medRxiv. 2022. PMID: 35794899 Free PMC article. Updated. Preprint.
Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa.
Hussey H, Vreede H, Davies MA, Heekes A, Kalk E, Hardie D, van Zyl G, Naidoo M, Morden E, Bam JL, Zinyakatira N, Centner CM, Maritz J, Opie J, Chapanduka Z, Mahomed H, Smith M, Cois A, Pienaar D, Redd AD, Preiser W, Wilkinson R, Chetty K, Boulle A, Hsiao NY. Hussey H, et al. Among authors: preiser w. medRxiv [Preprint]. 2022 Dec 5:2022.12.01.22282927. doi: 10.1101/2022.12.01.22282927. medRxiv. 2022. PMID: 36523408 Free PMC article. Preprint.
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Davies MA, Kassanjee R, Rosseau P, Morden E, Johnson L, Solomon W, Hsiao NY, Hussey H, Meintjes G, Paleker M, Jacobs T, Raubenheimer P, Heekes A, Dane P, Bam JL, Smith M, Preiser W, Pienaar D, Mendelson M, Naude J, Schrueder N, Mnguni A, Roux SL, Murie K, Prozesky H, Mahomed H, Rossouw L, Wasserman S, Maughan D, Boloko L, Smith B, Taljaard J, Symons G, Ntusi N, Parker A, Wolter N, Jassat W, Cohen C, Lessells R, Wilkinson RJ, Arendse J, Kariem S, Moodley M, Vallabhjee K, Wolmarans M, Cloete K, Boulle A. Davies MA, et al. Among authors: preiser w. medRxiv [Preprint]. 2022 Jan 12:2022.01.12.22269148. doi: 10.1101/2022.01.12.22269148. medRxiv. 2022. PMID: 35043121 Free PMC article. Updated. Preprint.
The surge of mpox in Africa: a call for action.
Nachega JB, Sam-Agudu NA, Ogoina D, Mbala-Kingebeni P, Ntoumi F, Nakouné E, Njouom R, Lewis RF, Gandhi M, Rosenthal PJ, Rawat A, Wilson LA, Kindrachuk J, Liesenborghs L, Mills EJ, Preiser W, Rimoin AW, Sullivan NJ, Peeters M, Delaporte E, Baxter C, Harrison L, Hermans MP, Mohr EL, Gonsalves G, Ndembi N, Zumla A, Muyembe-Tamfum JJ; Mpox Research Consortium. Nachega JB, et al. Among authors: preiser w. Lancet Glob Health. 2024 May 9:S2214-109X(24)00187-6. doi: 10.1016/S2214-109X(24)00187-6. Online ahead of print. Lancet Glob Health. 2024. PMID: 38735300 Free article. No abstract available.
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants.
Jaumdally S, Tomasicchio M, Pooran A, Esmail A, Kotze A, Meier S, Wilson L, Oelofse S, van der Merwe C, Roomaney A, Davids M, Suliman T, Joseph R, Perumal T, Scott A, Shaw M, Preiser W, Williamson C, Goga A, Mayne E, Gray G, Moore P, Sigal A, Limberis J, Metcalfe J, Dheda K. Jaumdally S, et al. Among authors: preiser w. Nat Commun. 2024 Mar 5;15(1):2003. doi: 10.1038/s41467-024-45400-1. Nat Commun. 2024. PMID: 38443359 Free PMC article.
An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable For Genomic Surveillance Within Clinical Diagnostic Settings.
Tshiabuila D, Choga W, James SE, Maponga T, Preiser W, van Zyl G, Moir M, van Wyk S, Giandhari J, Pillay S, Anyaneji UJ, Lessells RJ, Naidoo Y, Sanko TJ, Wilkinson E, Tegally H, Baxter C, Martin DP, de Oliveira T. Tshiabuila D, et al. Among authors: preiser w. medRxiv [Preprint]. 2024 Jan 25:2024.01.19.24301519. doi: 10.1101/2024.01.19.24301519. medRxiv. 2024. PMID: 38293032 Free PMC article. Preprint.
204 results